tv White House Briefing CSPAN May 11, 2018 2:58pm-3:44pm EDT
war on libya. and anything that was part and parcel of that whole arrangement, which the iran deal was, to perpetrate these complexes, i think the guest is right. that is what the cia does. the perpetrate conflicts because they make money on that. guest: i don't remember saying that. host: the viewer. guest: yeah, the viewer said that. i never said that. caller: we have in in wars continuously since world war ii.
you go back all that way. good afternoon. the president just finished rolling on new actions and proposals to jot down trump prices for all americans. the current situation is unacceptable and fixing jump prices is a top irony for the president. the blueprint will seek to
encourage innovation while promoting better competition and reform. the department of health and human services will take a range of immediate actions to implement the president's plan. i would like
to welcome secretary azar to the podium to speak about this and take a few questions to speak about the secretary azar: thank you. good afternoon, everyone. president said earlier we need to put america's patients first and not take advantage of them. i want to put a frame together for the actions you will see in and what the, president and i talked about today so you have a sense of where we are going here. problems, highor list prices for drugs, andrnment rules that teddy the way of plans getting good deals for our senior citizens in
our medicare programs. the third is foreign countries free writing off american innovation and the fourth is -- high,et out-of-pocket costs especially for our seniors. the administration has already made a lot of progress. the fda has approved more generic drugs than ever before $8.8 billionaving in the first year. we changed medicare reimbursement rules to bring for out of pocket spending senior citizens, saving them $320 million out of pocket for the drugs they by each year. work we ared the laying out now is focused on four strategies. to help fix this complex problem we face. first. increased competition, third, incentives to lower list prices and forth, lowering out-of-pocket costs. it is crucial we have more competition in prescription drug
markets. that means we need a vital generic drug industry and generic drug market. we need to nurture a new competitive generic drugthat me, generics for those complex, expensive biologic medicines. we need to foster and nurture that. we have to get after pharma companies that engage in anticompetitive practices and try to block the entry of generics or bio similar products to market, like for instance blocking access to their products so they can't do studies they need to do in order affordableoval of an generic or bio similar product. bring morehave to private sector negotiation to our medicare program to get the best deals. the part d discount program is now 15 years old. created it there when we
and it is still a great program the best at negotiating great deals for our senior citizens and was really able to drive tight formularies that were very efficient and that is what kept that part d drug plan cost below forecast. so often15 years, as happens with government programs, it got frozen in place, and the private sector kept adapting and learning, especially after the economic crisis of 2007, how to control drug spending even better. part d stayed static. the same toolsg available to the private sector sothose part d drug programs they can drive great deals for our seniors. we also have part b, these are drugs the physician administers.
paid right now are basically on a list price, plus a markup read there is no negotiation involved in that it all, and the president has proposed, we have got to figure out a way to move those drugs, especially the high cost ones, into the part d negotiations so that we can start getting bargains on that for our seniors and taxpayers. look at other mechanisms and you will see some other ones in the blueprint that also help us negotiate better deals. and this is a complex area. right now we have to bring incentives to lower list drug prices. incentive inery the system is to increase and have high list drug prices, because everybody in the system except the patient and taxpayer is wetting their beak along the
way. they are getting a percent of that list price. everybody makes more money along math just works that way. we need to flip the incentives so that it financially makes less sense to increase prices. one of the things we are going indo, i talked about this the rose garden, is we are that you have to -- disclose the list price of your drug. if the patient is having a discussion with a doctor about a drive, telling them all the good do, it ist drug can relevant to know if it is a $50,000 drug or a $100,000 drop, because often the patient is going to bear the cost. we have in medicaid and
medicare key incentives we can turn around on list prices. as part of obamacare, one of the
deals with the pharma industry was capping statutory rebates on drugs in the medicaid program at 100%. we are going to work with congress to lick at overturning that cap on rebates. that will make the math work so that when you increase your list cost you is going to more money if you are a pharma executive thinking about raising prices. we also want to think about creative ideas in our programs about reversing those incentives. right now in our drug discount program, if you have a drug that fits into one of these protected it is a most impossible for the drug plan to negotiating get any kind of discount from you. say, you onlyd we get to be in the protected class if you have an raised your list price in the previous 18 months? you can besay,
exempt from the specialty tears, or the patient has to pay a lot of out-of-pocket, but only if you haven't increased your list price in the last 18 months. the other big area we have to look at is the entire system of rebates that we have with pharmacy benefit managers. we are calling into question entire structure of using rebates as the method of negotiating discounts in the pharmacy channel, because right now, every incentive as for the drug company to have a very high list price and to negotiate a rebates down, often in a very nontransparent way. said, nonstead we rebates, flat price, fixed price in the contract, takeaway what is called the gross-to-net spread that makes people in different to what the list price is in that system, and takes away the incentives or even the pharmacy benefit manager makes money from higher list prices.
we also have a real issue we have to look at, which is the role of compensation for pharmacy benefit managers. they are taking it now from both sides. the get compensated by customers, the insurance companies, but they also get compensated by the drug companies they are supposed to be negotiating against. they are getting rebates and keeping some of the rebate. they are getting administrative fees. should we move to a fiduciary model where the pharmacy benefit manager works for the insurance company and the individual, and only is compensated by the ,nsurance company or individual forbid renumeration from the pharmaceutical company? so it is all completely on one side, a complete alignment of interests. and finally, how do we lower out-of-pocket drug costs? we are going to get rid of the gag rules. benefitw, some pharmacy managers are telling
pharmacists, you are not allowed to tell patients at that if they pay cash or this generic drug, it would be cheaper than if you run it through your insurance. we think that is unconscionable and in part d we are going to block that. we also think it is a right that when you are with your doctor, you want to be able to know what you're out-of-pocket is for a drug that you are going to be prescribed under your precise drug plan. you want to have that information, and you want to have information on what competing drugs are that your doctor is not prescribing, and what you would pay out-of-pocket for that. and that ought to to be across the part b plan and a part d plan. this doctor has an infusion clinic as part of their office and they write you a drug that might be an infused drug. you have a $300 co-pay for that. well, wouldn't you like to know that if the doctor instead wrote you an injectable drug? we think that will also help
drive real savings in the system. there are over 50 actions that we have in the blueprint. and this is not one and done. we are learning, we are open, we are hearing, we want this to be an active, ongoing process. this doesn't get solved tomorrow. it is going to take years of restructuring the system. but these are big, bold steps, a the mostsive attack -- comprehensive attack on drug affordability by any present carried on just glad president trump is encouraging us to do these bold measures. let me open it up to questions. reporter: there is a tremendous number of moving parts in this, many of which will require legislative action. how much of this works without the rest? can you do just part of it, and how much can be done through executive action versus legislation? most of this, we
believe can be done by executive action. we are happy to work with congress. so many of these solutions auto attract bipartisan support -- bipartisantract support. we believe most of these actions are steps we can take using our regulatory authority, especially with the power in the medicare program. few of them are interdependent, so it is not as if any one as requiring a preceding act. we think we can attack many of these steps. it is complex, because the system is rocket science, it is unbelievably complex. it is a very sophisticated approach, hitting so many of the financial and business levers by the system. instead of throwing political speak at this, as it would have been easy to do, it is a very business mindset focus on how you change the underlying financial levers here to genuinely solve the problem.
that is what the president wants, he wants us to solve the problem and lead to results. reporter: how soon will consumers see results? they are already seeing -- they are already seeing results from last year, $320 million already. we are certainly moving forward with any of these changes to make sure that they are going to see it in the pocket book right away. it is going to take time. some of this will take regulatory action. we will have to go through the administrative process, but i can tell you, as soon as i walked out of the rose garden, the first president -- the first question the president has was -- had was, we will have a meeting next week on a timeline and get it all done. it is going to be months for the
kind of actions we need to take care. decades to erect this very complex, interwoven system. we are talking about entrenched market layers, complex financial arrangements that have to be redesigned. i don't want to overpromise that somehow on monday there is a radical change. commitments a deep that this is fundamental structural change we are talking about. reporter: [indiscernible] -- can yoga help, maybe you don't need any drugs if you have yoga? i will address
the generic drugs. competition in our system is absolutely vital. that is why you have the deep commitment of the administration to remove any anti-competitive barriers. reporter: is this calling into question the entire rebate structure? when might consumers see movement on that? secretary azar: we are releasing a request for information. that is the initiation for seeking input. restructuringible of a major sector of the economy. one does not do that lightly. it is beginning a national dialogue with the public, with ifkeholders, with congress, we were to outlaw rebates in the part d drug discount program and instead require that the products be discounted at a fixed price. just took slain how this works now. let's say you have a one dozen dollar drug. you go to the pharmacy benefit manager and say, if you cover my
drug i will give you a 30% rebate on that after the fact. so a $300 rebate on that. what this would say, instead of that he would have to negotiate a contract and it would say, you get reimbursed $700 this year. maybe $702 next year, for some inflation, so it is fixed. what goes on that is frankly a company game, the drug negotiates the 30% rebate. and then the next day increases price 30%. it is this game of taste that goes on. instead, fixed price, make everything indifferent to this list price, and all the fees not be based on a percentage of this artificial list price, which for so many people is like the rate on the back of your hotel room door. almost nobody pays it but a lot of people are paying it and they
are suffering from it. this is out today, we want to see comment and learn and move forward on that if it makes sense. need to learn how to restructure things. i believe one pharmacy benefit manager yesterday talked about this precise issue of restructuring their contracts, to get out of this rebate spread conundrum that the world is in. i believe it will have tremendous systemic impact. reporter: there are a couple of notorious examples of drug companies buying drugs that of been on the market for years and raising their prices extraordinarily. is there anything in this blueprint that addresses that, like the epipen situation? there is buried one of the elements of increasing power during negotiation is, if a soul-source whatic drug, which is these drugs are, when you have one generic drug out there, and if there is any increase in price by a soul-source -- by a
generic drug, we are going to take action against that drug. right now they have to wait for the end of the year and the new plan cycle, but they can immediately go up to that drug and come after -- come up with alternative drugs or create preferential treatment for other drugs over that other one if there is any increase in price over a sole-source generic. reporter: in maryland and , insurers are talking about double-digit health insurance premium increases. there is a maryland regulator that said something like, the aca is in a death spiral. what are you doing to deal with that? should we accept these premium predictions as reality? some premiumr: submission is right now, it is the very beginning of a process that goes on with state
legislators. these were going on under obama and they continue under howctural infirmities about obamacare was designed. that is why the president has been adamant about affordable options for patients, is the 28 million forgotten men and women of this country have been forced out of the individual market and they are without insurance, despite the promise of competitive, affordable insurance they could keep. 6.7 million americans paid $3.1 billion in the obamacare taxes for the privilege of not buying insurance that they couldn't afford and didn't want. make $50,000 or less. we are trying to bring short-term plans as an option for people. we are trying to bring association health plans out of the labor department, as options for people. the president wants to keep looking for more options to get people out of some of the traps of the obamacare system has
created with these high-cost and uncompetitive plans for people. i have a question about another issue. the justice department has indicated the department is set to change an obamacare world that would bar medicare practitioners from denying medical treatment for transgender people. will hhs kill that rule? secretary azar: i'm not familiar with that. am going to talk about drug prices. into that when i get back to the department. reporter: you talked about medicare part d negotiating better prices. thing thee same president referred to when he said other countries that have socialized medicine's are ripping us off? why is that ok for medicare and not other countries? differencezar: the is having entities negotiate in a competitive environment. what happens in some of these
socialist countries is, they say it you don't come into this country unless you pay this low price. here is a below market, non-competitive price, you either pay it or you don't come into this country. and they don't really care for people of the country don't get access to their drug, and people aren't informed even that they don't have access to that medicine in these rationed systems. so that is completely different from what we are doing, where we are harnessing the power of the private negotiating market to negotiate deals. part d works, the system we want to emulate and use tools from in that part be is, one drug plan might say, i am not quite to cover the drug because i didn't get a good enough deal. and then a number -- and then another drug plan might cover that drug because they think they got a good deal. in the key is the citizen the drivers seat. they get to choose. they say, i need that drug, i
will get this plan and play the premium for this plant. if you are in a socialized country, you can't exit except for getting on a plane to america when you can get access to the program. reporter: when people hear about this plan, they are presumably going to learn about yourself as and you might say wait a minute. somebody who is a f -- who it is a farmer executive is going to negotiate drug prices? secretary azar: i would say trust us by our actions and our deeds in the blueprint. it is the hardest hitting action ever proposed by a president, across the entire spectrum of every player in this industry, to make drugs more affordable. i know this from having been on the other side, running a drug company, and these issues. youtually looked at if
could lower drug prices. it didn't work for any one company. this is how prefers the system is. you put yourself at a disadvantage in the system by having a lower list priced drug than others, because every player in the system makes more money as a percent off that list price. i am soprecisely why excited to be here in government, with the knowledge that i have got and this team has, about how we can change the rules of the road and change the can reversehat we those incentives to make that work, make those choices work, bring down drug prices and make things more affordable. secretary azar: one of the reasons you could lower the price when you were running a big pharmaceutical is that you were at a disadvantage? the math doesn't work. secretary azar: the system doesn't make that work. my job with the president's commission is to make that work on us of the incentives were to actually bring prices down, charge less on the list price,
that is exactly what we are about. no one company on their own can change that dynamic. entire system is actually built for increased prices and high prices. this plan reverses those dynamics. the president said in the president said in i want to askn, what about the process that you are going to change if it extends beyond the budget andosal from one month ago, if we will see increased enforcement? secretary azar: i will give you one or two examples of the abuses we are talking about. to bring a generic drug or a bio similar to market, you have to prove your version of it is by a wee equivalent that is
bioequivalent. you have to have access to the medicine to run the tests and studies but what some companies are doing is locking down access to those medicines, hiding medicines, hiding behind these safety programs of the fda, and even when fda says, no, you can share that for clinical trial testing, they are also creating limited distribution agreements with distributors to not allow these generic companies access to them. and that is one of the things we going to be going after. we will make sure these anti-competitive behaviors that don't allow affordable medicines to go to market, we will blows away. take you all, very much. factor, multi-stakeholder approach, it is the most comprehensive and i look forward to the days and weeks ahead to keep engaged with you and help you walk through all the different elements of it as you have a chance to digest it.
will americans be able to buy drugs from canada? ms. sanders: thank you, mr. secretary. i would like to wish a happy birthday to america's oldest living veteran from world war ii, richard overton. richard is turning 112 years old today. he served in the pacific from 1942 to 1945 as part of the all-black engineer aviation battalion. happy birthday, richard, and thank you for your service. speaking of those with a lot of candles on their cake, i would wish general john kelly happy birthday. and looking ahead to sunday, happy mother's day. as a note of free advice, don't forget to call your mom's and you might even buy flowers if you feel inclined. cam summit --he the kim jong-un summit, we were told the summit can be a daylong
summit. what is the best case scenario of what can be accomplished in a single day? to sanders: i'm not going get ahead of those conversations. as you stated, we plan for a full day of meetings on the 12th with time reserved to carryover if necessary. best outcome would be an agreement for complete and total denuclearize asian -- denuclearize asian. denuclearization. but i'm not going to get ahead of those conversations. reporter: do you think i can happen in one day? secretary azar: again, i'm not -- ms. sanders: again, i'm not going to get ahead of those conversations but there have been conversations leading up to the meeting and secretary pompeo
has had two meetings leading up to this process. so it is not just one day. you have a look at the broader picture, but certainly we have the time set aside at this point. reporter: i want to ask about the meeting earlier today. does the president agree with their position? agreede administration to open negotiations with california? ms. sanders: we haven't finalized what that looks like, but today was part of the conversation on how best to move forward. to continue these conversations and if we have a specific policy announcement we will a you know. reporter: coming back to north korea, the president says he believes it is kim jong-un's attention to denuclearize, but when you listen to the person in
charge of north-south relations he says, the reason we are doing this is because our nuclear program is complete. the reason we are shutting down our test sites is because our nuclear program is complete. it's kind of akin to someone who builds a house and then enters -- aa negotiating negotiation to tear down. what gives you confidence came is willing tokim tear down something he just built up? ms. sanders: this is certainly a process that has moved in the right direction. we have seen signs of goodwill from north korea just this week, with the three americans brought the stopping of ballistic missile tests and them stopping research and development on their nuclear program. and we are going to continue to push for complete and total denuclearization.
we are going to continue maximum pressure until we see that happen. testing, stopping this they say they don't need it anymore that they are done. they can put the saws and hammers away because the house has been built. ms. sanders: the president has been very clear that we are going into this, certainly we would like to see something happen, but as he has said many times, we are going to see what happens. and we hope, not just for north korea but the entire world, that they do the right thing and that this goes the way everyone would like to see. bothter: at&t and novartis said it was a mistake for their companies to work with the president's lawyer. does the president think it was a mistake for his lawyer to work with them? ms. sanders: this further proves the president isn't going to be influenced by special interests. it is actually the definition of draining the swamp, something the president talked about repeatedly. for anything beyond that i would
refer you to the outside counsel. reporter: the definition of draining the swamp? ms. sanders: it is pretty clear that department of justice to post the merger -- justice opposed the merger, so the president has not been influenced by any outside interests. reporter: you said in this room the other day that it is unlikely there will be an infrastructure bill this year. be thes supposed to signature legislative item of 2018 for republicans and this administration. the white house 's legislative agenda for the rest of this year? to sanders: we would like see something done on immigration. we have laid out the principles and priorities we would like to see as part of an immigration package. some movement on that front end we would like to see something happen. we would love for congress to actually show up and do their
job, and democrats to stop opposing this legislation and fix our broken immigration system. meanter: did that immigration is the signature item now? ms. sanders: it has been a constant priority for the president. have heard a lot about white house aide kelly sattler and her comments about senator mccain, reportedly saying in a meeting that the resident shouldn't worry about the senator's opposition to the nomination of gina haspel because he is dying, anyway. whyan mccain wondered aloud kelly sattler has a job at the white house. i she still have a job? ms. sanders: i am not going to comment on an internal staff meeting. president trump says he still has faith in epa administrator scott pruitt. do you know if he was aware about these new freedom of information act documents that showed administrator pruitt had dinner last year in rome with a catholic cardinal who was under
investigation for child sex abuse? ms. sanders: i'm not aware of that. i haven't spoken with the president about administrator pruitt. does the white house not feel the need to condemn kelly sattler's remarks? ms. sanders: i'm not going to comment on a layer the other out of than internal staff meeting. i'm not going to validate a leak out of an internal staff meeting one way or another. reporter: does the president regret what he said during the campaign, about john mccain, when he said he wasn't a war hero and supports people who weren't captured? ms. sanders: i have talked with him specifically about that. reporter: if you won't comment on the specific comment, what does the white house believe about senator mccain? is there a tone set from the top where it is allowed from the aid, he is dying so it doesn't matter? ms. sanders: certainly there is not a town set here. we have a respect for all
americans. and that is what we try to put thing we do,ery both in word and action, focusing on doing things that help every american every single day. and i think if you look at the policies we have put fort, you will see that policy reflected. reporter: when i apologize to senator mccain? ms. sanders: i'm not going to get into a back and forth about leaks. we have said many times before, if the president know longer has confidence in a cabinet member he will let you know. reporter: what more does the president think brigitte nielsen can do now under the law, -- that kiersten nielsen can do under the law? ms. sanders: the president wants us to do a number of things. he wants us to work with we have laid out
time and time again and as we have called on them to do. if democrats in congress would stop playing political games, we would love to secure the border, we would love to close the loopholes in the system, we would love to get a fix on daca. we would like to get all of those things done. reporter: this he pushed republicans to get a floor -- does he pushed republicans to get a vote on the house floor? we would support anything to fix the broken immigration system. the homeland security secretary last night said the president was rightly frustrated by congressional action. why was that frustration expressed for the secretary herself? she didn't serve in congress and could only do what was enacted in law by congress, so why did the president direct his frustrations at her? ms. sanders: i'm not going to get into a back and forth with you guys on an internal meeting but i can tell you the president and secretary share the frustration that congress is not showing up to work in getting the job done democrats have got to stop playing games, they have
to stop doing this just because it is a midterm year. they still have to do the job and we would like to see them fix our immigration system. administration frustrated, but americans are. 80% of americans would like to see this problem fixed. they are begging congress to do it, and the president has a right to be frustrated, and he is a right to be angry, and he is, and he is going to express that. he is going to continue to do that until we fix this problem. reporter: is the white house meetcked -- on track to speaker ryan's deadline next week on nafta? ms. sanders: we have made progress and hopefully we will get there. is the president willing to revisit this after the elections in med -- elections in mexico in the midterms? ms. sanders: we really know. reporter: this kelly sattler still work in this white house? ms. sanders: yes.
she does. reporter: does the president their responsibility for the tone in this white house? ms. sanders: the president supports all americans. if you look at what he is doing every day, he is working hard to make this country better, whether it is building our the economy, creating jobs, defeating isis, fixing our judiciary system, helping with illegal immigration, the president is addressing a number of issues. that is what our focus is. that is what we are doing your every day and that is what the president has laid out very clearly, what his interests are. reporter: does he bear responsibility for the tone set here at the white house and the staffers who work here? ms. sanders: he certainly doesn't it think he's done a good job laying out what the priorities of the administration and what they are doing is helping impact americans all across the country. are they lying, sarah?
reporter: general kelly came out and endorsed a pathway to citizenship for temporary protected status recipients you have been in the u.s. for some time. does the president share general kelly's view on that? ms. sanders: i haven't seen that specific comment from the interview. both of the president and general kelly want to fix the system but i would have to look at that specific comment. reporter: the general kelly oppose the administration bush to give a deadline to people who have lived in the country for 20 years? ms. sanders: i would have to look at the comment before i could weigh in. there is a huge stake on whatever trump and kim
jong-un agree upon. will president moon or another representative south korea be at the talks? ms. sanders: i don't think there are plans for them to be there on that specific day, but certainly they have been a partner in this entire process. president moon will be here on the 22nd to continue those conversations, and we continue to be in lock step with the south koreans. reporter: on wednesday the president tweeted, the fake news is working overtime. 91% of the network news about me is negative, fake. are all negative stories about the president fake? ms. sanders: no. reporter: why did he say that than? ms. sanders: i will take one last question. reporter: i want to follow up on the payments michael cohen received from at&t and novartis. you say it's a sign the president won't be compromised but does the president think it is appropriate for his personal
attorney to collect payments from private companies, to influence policy of give them strategies to influence policy? ms. sanders: the president is going to be influenced by outside special interests. he is going to do what he sees as the best interest of americans across the country. have a great weekend, and happy mother's day. >> finishing up the briefing here on the heels
of president trump's earlier announcement to get drug prices cut. house minority leader nancy pelosi responded with a statement that says, the plan abandons millions of hard-working families struggling the crisis of surging drug prices. the proposals are another big of a way to big pharma and do nothing to hold wealthy drug companies accountable for their
price gouging. that is from minority leader nancy pelosi. you can see the announcement anytime online on c-span.org. >> the chair of the house -- houseongress freedom congress, congressman mark meadows, talks about a government accountability audit of the robert mueller investigation. here is a short portion of his remarks. congressman meadows: there will be a request for us to audit the financial resources of this investigation. he used to be part of the statue. it is within the parameters, since it is an appropriated fund from congress. we will be sending a request to the gao, the general accountability office, to actually look at an audit and make sure those funds are put forth properly. a question from the oversight committee or the freedom caucus? representative meadows: any
member of congress can do that. and i will be doing that in at least my personal capacity, but as you know i am chairman on the subcommittee of government operations so gao and others are under that subcommittee. so we will be sending that out to see who else would join. >> to audit spending for the mueller investigation? congressman meadows: yes, because that comes out of a dedicated fund, what we call back door appropriations. be inside baseball language, but making sure what we are doing is properly spending that. dollars 3 million plus spent or potentially not spent in a correct manner. i'm not making any conclusion to that because i was once to back up what i have, but we believe we need to look at that little bit closer. portion of freedom caucus chair mark meadows' recent comment from our
"newsmakers" program. you can watch the entire conversation online at c-span.org. -- q and cue and day barbaraversity of santa author, who wrote inseparable, the book about the siamese twins. >> these were two married couples who could not be in the same bed. up two separate households about a mile from and they stuck to this very rigid schedule. say stay in tanks fore i -- chang's house three days with chang's wife.
and the other twin would give up his free will. and three days later, they would house, the other twin's and he would be the master of the house and then chang would give up his free will. >> did it work? >> apparently. they had 21 children. connect with c-span to personalize the information you get from us. just go to c-span.org/connect and sign up for the email. the program guide is a daily email with the most updated, primetime schedule and upcoming live coverage. word for word gives you interesting daily highlights in their own words, with no commentary. the book tv newsletter sent weekly as an insider look at upcoming authors and books festivals. and the american history tv weekly newsletter gives you exploringrogramming
our nation's past. sign-up today. week, the house energy and commerce subcommittee on energy reviewed activities of the electric transmission sector. witnesses discussed ways to improve the grade including new transmission lines. they talked about federal laws and regulations on the sector. this is about one hour and 20 minutes.